These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35618787)

  • 1. Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Weller D; Falborg AZ; Jensen H; Butler J; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Fourkala EO; Gavin AT; Grunfeld E; Harland E; Kalsi J; Law RJ; Lin Y; Turner D; Neal RD; White V; Harrison S; Reguilon I; Lynch C; Vedsted P;
    Br J Cancer; 2022 Sep; 127(5):844-854. PubMed ID: 35618787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
    BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
    Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
    BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
    Vedsted P; Weller D; Zalounina Falborg A; Jensen H; Kalsi J; Brewster D; Lin Y; Gavin A; Barisic A; Grunfeld E; Lambe M; Malmberg M; Turner D; Harland E; Hawryluk B; Law RJ; Neal RD; White V; Bergin R; Harrison S; Menon U; ;
    BMJ Open; 2022 Dec; 12(12):e059669. PubMed ID: 36521881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study.
    Tørring ML; Falborg AZ; Jensen H; Neal RD; Weller D; Reguilon I; ; Menon U; Vedsted P
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13100. PubMed ID: 31119836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership.
    Lynch C; Harrison S; Emery JD; Clelland C; Dorman L; Collins C; Johansen ML; Lawrenson R; Surgey A; Weller D; Jarbøl DE; Balasubramaniam K; Nicholson BD
    Br J Gen Pract; 2023 Feb; 73(727):e88-e94. PubMed ID: 36127155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathway to diagnosis and treatment for surgically managed lung cancer patients.
    White V; Bergin RJ; Thomas RJ; Whitfield K; Weller D
    Fam Pract; 2020 Mar; 37(2):234-241. PubMed ID: 31665265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations and referral for suspected cancer in primary care in New Zealand-A survey linked to the International Cancer Benchmarking Partnership.
    Htun HW; Elwood JM; Ioannides SJ; Fishman T; Lawrenson R
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28105767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.
    Nicholson BD; Mant D; Neal RD; Hart N; Hamilton W; Shinkins B; Rubin G; Rose PW
    Br J Gen Pract; 2016 Feb; 66(643):e106-13. PubMed ID: 26740607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsibility for follow-up during the diagnostic process in primary care: a secondary analysis of International Cancer Benchmarking Partnership data.
    Nicholson BD; Goyder CR; Bankhead CR; Toftegaard BS; Rose PW; Thulesius H; Vedsted P; Perera R
    Br J Gen Pract; 2018 May; 68(670):e323-e332. PubMed ID: 29686134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
    Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
    Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
    Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
    Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions.
    Rose PW; Hamilton W; Aldersey K; Barisic A; Dawes M; Foot C; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Thulesius H; Vedsted P; Young J; Rubin G;
    BMC Fam Pract; 2014 Jun; 15():122. PubMed ID: 24938306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "There's Not Enough Bodies to Do the Demand": An Exploration of Key Stakeholder Views on the Role of Health Service Capacity in Shaping Cancer Outcomes in 7 International Cancer Benchmarking Partnership Countries.
    Seguin M; Morris M; McKee M; Nolte E
    Int J Health Policy Manag; 2022 Jul; 11(7):1024-1034. PubMed ID: 33589567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
    Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
    Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.